Amicus Therapeutics (NASDAQ:FOLD) prices its private offering of 3.00% convertible senior notes due December 15, 2023 at par. The conversion rate is 163.3987 common shares per $1,000 principal amount of the notes ($6.12/share). Initial purchasers have the option to buy up to an additional $25M of the notes.Closing date is December 21.
Yesterday's close was $4.80.
Subscribe for full text news in your inbox